Albireo Pharma (ALBO) Reports FY16 Loss of $13.16

Albireo Pharma (NASDAQ: ALBO) reported FY16 EPS of ($13.16), versus ($25.49) reported last year. Revenue for the year came in at $11.4 million, versus $5.1 million reported last year.

For earnings history and earnings-related data on Albireo Pharma (ALBO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c